%PDF-1.4
%
1 0 obj
<>stream
iText 4.2.0 by 1T3XT2019-04-01T17:46:55+05:30Arbortext Advanced Print Publisher2019-07-10T00:10:22-07:002019-07-10T00:10:22-07:00uuid:8addd02c-2a8d-4824-a074-0375b52bef83uuid:9735c38c-787b-4f5b-aca7-e8422204bc96JournalGynecological Endocrinology© 2019 Informa UK Limited, trading as Taylor & Francis Group0951-35901473-0766001-71710.1080/09513590.2019.1590699https://doi.org/10.1080/09513590.2019.1590699application/pdf10.1080/09513590.2019.1590699en-USCould interleukin-33 and its suppressor of tumorigenicity 2 (ST2) receptor have a role in cervical human papillomavirus (HPV) infections?Taylor & FrancisGynecological Endocrinology, 2019. doi: 10.1080/09513590.2019.1590699Kulhan Nur GozdeKulhan MehmetAydin MerveNayki UmitNayki CenkUlug PasaAta NahitMertoglu CumaCikman AytekinSayar İlyasTurkler CanHuman papillomavirusinterleukin-33suppressor of tumorigenicity 2 (ST2)receptorcervical cancerVoR2019-04-02truewww.tandfonline.com10.1080/09513590.2019.1590699www.tandfonline.comtrue2019-04-0210.1080/09513590.2019.1590699
endstream
endobj
4 0 obj
<>stream
xYˎ%
߯DC%hpvNbUb;$EJ{